Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandro Pasquali

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 14, 2018
Quality assurance in melanoma care: The EU-MELACARE studyAntonio Sommariva, Ana-Maria Forsea, Domenic Agius, et al.
Cancers|July 24, 2019
Comparative Assessment of Antitumor Effects and Autophagy Induction as a Resistance Mechanism by Cytotoxics and EZH2 Inhibition in INI1-Negative Epithelioid Sarcoma Patient-Derived XenograftSilvia Stacchiotti, Valentina Zuco, Monica Tortoreto, et al.
Eclinicalmedicine|February 12, 2026
Early recurrence and prognosis in patients undergoing resection of primary retroperitoneal sarcoma: an international, retrospective cohort studyAlessandro Gronchi, Sara Iadecola, Juliana Restrepo-López, et al.
Annals of Surgical Oncology|December 13, 2025
Refining the Contemporary Management of Primary Retroperitoneal Soft Tissue Sarcoma: Outcome Improvement Over Time at a Single InstitutionMarco Fiore, Francesco Barretta, Costanza Figura, et al.
Pediatric Blood & Cancer|May 21, 2025
Malignant Peripheral Nerve Sheath Tumor in Children and Adolescents: Local Treatment in a Retrospective Single-Center ExperienceAndrea Ferrari, Luca Bergamaschi, Stefano Chiaravalli, et al.
European Journal of Cancer (Oxford, England : 1990)|February 24, 2018
High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trialSandro Pasquali, Chiara Colombo, Sara Pizzamiglio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2024
GDF-15 Predicts Epithelioid Hemangioendothelioma Aggressiveness and Is Downregulated by Sirolimus through ATF4/ATF5 SuppressionSilvia Stacchiotti, Silvia Martini, Sandro Pasquali, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 4, 2024
Proximal and Classic Epithelioid Sarcomas are Distinct Molecular Entities Defined by MYC/GATA3 and SOX17/Endothelial Markers, RespectivelyLuca Sigalotti, Anna Maria Frezza, Marta Sbaraglia, et al.
Ebiomedicine|July 17, 2024
Spatial distribution of tumour immune infiltrate predicts outcomes of patients with high-risk soft tissue sarcomas after neoadjuvant chemotherapySandro Pasquali, Viviana Vallacchi, Luca Lalli, et al.
JAMA Network Open|November 6, 2025
Histopathological Response After Neoadjuvant Chemotherapy for High-Risk Soft-Tissue Sarcomas: A Secondary Analysis of a Randomized Clinical TrialSandro Pasquali, Paola Collini, Cleofe Romagosa, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 14, 2018
Quality assurance in melanoma care: The EU-MELACARE studyAntonio Sommariva, Ana-Maria Forsea, Domenic Agius, et al.
Cancers|July 24, 2019
Comparative Assessment of Antitumor Effects and Autophagy Induction as a Resistance Mechanism by Cytotoxics and EZH2 Inhibition in INI1-Negative Epithelioid Sarcoma Patient-Derived XenograftSilvia Stacchiotti, Valentina Zuco, Monica Tortoreto, et al.
Eclinicalmedicine|February 12, 2026
Early recurrence and prognosis in patients undergoing resection of primary retroperitoneal sarcoma: an international, retrospective cohort studyAlessandro Gronchi, Sara Iadecola, Juliana Restrepo-López, et al.
Annals of Surgical Oncology|December 13, 2025
Refining the Contemporary Management of Primary Retroperitoneal Soft Tissue Sarcoma: Outcome Improvement Over Time at a Single InstitutionMarco Fiore, Francesco Barretta, Costanza Figura, et al.
Pediatric Blood & Cancer|May 21, 2025
Malignant Peripheral Nerve Sheath Tumor in Children and Adolescents: Local Treatment in a Retrospective Single-Center ExperienceAndrea Ferrari, Luca Bergamaschi, Stefano Chiaravalli, et al.
European Journal of Cancer (Oxford, England : 1990)|February 24, 2018
High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trialSandro Pasquali, Chiara Colombo, Sara Pizzamiglio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2024
GDF-15 Predicts Epithelioid Hemangioendothelioma Aggressiveness and Is Downregulated by Sirolimus through ATF4/ATF5 SuppressionSilvia Stacchiotti, Silvia Martini, Sandro Pasquali, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 4, 2024
Proximal and Classic Epithelioid Sarcomas are Distinct Molecular Entities Defined by MYC/GATA3 and SOX17/Endothelial Markers, RespectivelyLuca Sigalotti, Anna Maria Frezza, Marta Sbaraglia, et al.
Ebiomedicine|July 17, 2024
Spatial distribution of tumour immune infiltrate predicts outcomes of patients with high-risk soft tissue sarcomas after neoadjuvant chemotherapySandro Pasquali, Viviana Vallacchi, Luca Lalli, et al.
JAMA Network Open|November 6, 2025
Histopathological Response After Neoadjuvant Chemotherapy for High-Risk Soft-Tissue Sarcomas: A Secondary Analysis of a Randomized Clinical TrialSandro Pasquali, Paola Collini, Cleofe Romagosa, et al.
Pageof 11